Assessing Use Of Mifepristone After Progestin Priming For Use As "Missed Period Pills"

Assessing Use Of Mifepristone After Progestin Priming For Use As "Missed Period Pills"

This study will assess the effectiveness and acceptability of a 3-day missed period pill regimen.

Missed period pills (MPPs) are medications used for uterine evacuation among women with late menses who have not confirmed pregnancy status. Provision of MPPs could expand reproductive service options for individuals in a variety of settings. This study will collect data on the efficacy, safety, and acceptability of a 3-day missed period pill regimen among individuals with missed menses of 1-10 days

Inclusion Criteria:

• Age 18-49 years
• General good health
• Does not want to be pregnant
• History of regular monthly menstrual cycles (±3 days)
• Missed menses of 1 to 10 days as verified by report of last menstrual period
• Sexual activity in the past month
• Willing and able to sign consent forms
• Willing to return for a follow-up visit
• Willing to provide a urine sample at enrollment and at follow-up

Exclusion Criteria:

• Known allergies or contraindications to mifepristone
• Symptoms of or risk factors for ectopic pregnancy, such as vaginal bleeding or spotting within the past week; unilateral pelvic pain or significant bilateral pelvic pain within the past week; prior ectopic pregnancy; prior permanent contraception or other tubal surgery
• Current use of an IUD, contraceptive implant or injectable